Researchers with the James P. Allison Institute at The University of Texas MD Anderson Cancer Center have discovered a new ...

Bay Area-raised host Ericka Cruz Guevarra brings you context and analysis to make sense of the news. Episodes drop Monday, Wednesday, and Friday. Emma’s Must-Sees See TV Programming Manager Emma ...

A new blood test could help doctors identify whether a treatment for advanced prostate cancer is failing weeks earlier than ...

Over half of patients in a randomized trial switch from enzalutamide to darolutamide because of cognitive issues; no one switches in the opposite direction.

If you’re dealing with advanced prostate cancer, the thought of surgery might feel like a lot to take in — and that’s completely understandable. For many men facing an advanced diagnosis, surgery will ...

CHICAGO -- Patients with advanced prostate cancer treated with enzalutamide (Xtandi) had a significantly greater decline in ...

The cognitive effects men with advanced prostate cancer experience during treatment may vary based on the therapy they ...

Add Yahoo as a preferred source to see more of our stories on Google. An innovative new drug being trialled to tackle certain cancers could also benefit patients with advanced prostate cancer whose ...

The vast majority of people diagnosed with prostate cancer can expect to live long, full lives thanks to improved screening that catches the disease in its early and most treatable stages. But ...

From AI-generated biopsy reports to new imaging techniques, these are the latest developments in advanced prostate cancer research that your doctor may be keeping tabs on. Much of managing advanced ...

Advances in radiotherapy are rapidly transforming how prostate cancer is treated, offering patients more precise, less invasive options that can fit more easily around everyday life ...